We determined the antimicrobial susceptibility of 90 clinical isolates of Stenotro-phomonas maltophilia collected in 2009 at a tertiary care hospital in Korea. Trime-thoprim-sulfamethoxazole, minocycline, and levofloxacin were active against most of the isolates tested. Moxifoxacin and tigecycline were also active and hold promise as therapeutic options for S. maltophilia infections.
- Antimicrobial susceptibility
- Stenotrophomonas maltophilia